{
"@context": "https://schema.org",
"@type": "Article",
"headline": "Louisiana Fourth Circuit Offers Clarification on the Role of Pharmaceutical Labeling and Package Inserts in Medical Malpractice Litigation: Deviation from manufacturer dosage instructions is not ipso facto evidence of breach",
"url": "https://www.lexblog.com/2014/04/07/louisiana-fourth-circuit-offers-clarification-on-the-role-of-pharmaceutical-labeling-and-package-inserts-in-medical-malpractice-litigation-deviation-from-manufacturer-dosage-instructions-is-not-ipso/",
"identifier": {
"@type": "PropertyValue",
"name": "LexBlog Library record",
"value": "LEX-WK-Y227B6HD",
"url": "https://www.lexblog.com/lib/Y227B6HD/"
},
"datePublished": "2014-04-07T11:45:34-04:00",
"dateModified": "2023-09-29T15:00:51-04:00",
"author": {
"@type": "Person",
"name": "Karen Fontana Young"
},
"sourceOrganization": {
"@type": "Organization",
"name": "Kean Miller"
},
"organizationScope": "at-publication",
"isPartOf": "Louisiana Law Blog",
"about": "Health Care and Life Sciences",
"sourceUrl": "http://louisianalawblog.wp.lexblogs.com/2014/04/louisiana-fourth-circuit-offers-clarification-on-the-role-of-pharmaceutical-labeling-and-package-inserts-in-medical-malpractice-litigation-deviation-from-manufacturer-dosage-instructions-is-not-ipso/",
"sourceStability": "may-move"
}